Sagespring Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.34M Buy
18,010
+2,285
+15% +$815K 0.12% 101
2025
Q4
$5.15M Buy
15,725
+1,671
+12% +$530K 0.09% 108
2025
Q3
$3.97M Buy
14,054
+438
+3% +$127K 0.08% 125
2025
Q2
$3.8M Buy
13,616
+1,454
+12% +$412K 0.08% 124
2025
Q1
$3.79M Sell
12,162
-2,343
-16% -$692K 0.1% 111
2024
Q4
$3.78M Buy
+14,505
New +$4.3M 0.1% 99

Other funds holding AMGN

Sagespring Wealth Partners's AMGN Position: Q1 2026 in Review

Sagespring Wealth Partners increased its Amgen (AMGN) stake by 15% in Q1 2026, buying an estimated $815K and bringing the position to 18,010 shares worth $6.34M. The position accounts for 0.12% of the portfolio, ranked #101.

Sagespring Wealth Partners first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Sagespring Wealth Partners held 18,010 shares of Amgen worth $6.34M as of Q1 2026.
  • Sagespring Wealth Partners bought 2,285 Amgen shares in Q1 2026, an estimated $815K.
  • Amgen made up 0.12% of Sagespring Wealth Partners's portfolio in Q1 2026, its #101 holding.
  • Sagespring Wealth Partners first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.